Clinical Trial Update: Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating panitumumab in combination with chemotherapy as second-line treatment for colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED